What is NDC 0264-8002?

0264-8002 is the product NDC for Midazolam In 0.8% Sodium Chloride, Midazolam 1 mg/mL injection, solution, listed with the FDA by B. Braun Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

B. Braun Medical Inc., NDC labeler code 0264. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Midazolam In 0.8% Sodium Chloride?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Midazolam In 0.8% Sodium Chloride NDC 0264-8002

NDC codes

FDA NDC Directory

Product NDC (as listed)0264-8002Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00264-8002Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0264-8002-32	0026480023200264800232	30 CONTAINER in 1 CASE (0264-8002-32) / 100 mL in 1 CONTAINERMarketed from Oct 15, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Midazolam In 0.8% Sodium Chloride
Generic name (nonproprietary): midazolam in 0.8% sodium chloride
Active ingredients: Midazolam — 1 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: B. Braun Medical Inc.NDC labeler code 0264
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218454
Marketing start: Oct 15, 2025
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 0264-8002_1287da80-6b0a-4ba3-b698-d1dc0e78c294SPL ID 1287da80-6b0a-4ba3-b698-d1dc0e78c294SPL set ID adfe8ece-496d-4118-9990-a1d44d0ac7d9RxCUI 2541170, 2541171UNII R60L0SM5BC
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400264800232 followed by a unit qualifier and the quantity

Package 00264-8002-32. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 15, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Midazolam in Sodium Chloride Injection is indicated: Continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting. Midazolam in Sodium Chloride Injection is a benzodiazepine indicated for: • Continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0264-8002

What is NDC 0264-8002?: 0264-8002 is the product NDC for Midazolam In 0.8% Sodium Chloride, Midazolam 1 mg/mL injection, solution, listed with the FDA by B. Braun Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Midazolam In 0.8% Sodium Chloride.
What is the active ingredient?: Midazolam.
Who is the labeler?: B. Braun Medical Inc., NDC labeler code 0264. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Midazolam In 0.8% Sodium Chloride?: 1 other product NDC are listed under this name. See all Midazolam In 0.8% Sodium Chloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Midazolam In 0.8% Sodium Chloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Midazolam In 0.8% Sodium Chloride	Midazolam 1 mg/mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-8005	00264-8005-31

Other NDCs under ANDA 218454

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218454
Product	Strength	Form · route	Labeler	Product NDC
Midazolam In 0.8% Sodium Chloride	Midazolam 1 mg/mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-8005